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Background: Maps of disease occurrences and GIS-based models of disease transmission risk are increasingly
common, and both rely on georeferenced diseases data. Automated methods for georeferencing disease data have
been widely studied for developed countries with rich sources of geographic referenced data. However, the
transferability of these methods to countries without comparable geographic reference data, particularly when
working with historical disease data, has not been as widely studied. Historically, precise geographic information
about where individual cases occur has been collected and stored verbally, identifying specific locations using place
names. Georeferencing historic data is challenging however, because it is difficult to find appropriate geographic
reference data to match the place names to. Here, we assess the degree of care and research invested in
converting textual descriptions of disease occurrence locations to numerical grid coordinates (latitude and
longitude). Specifically, we develop three datasets from the same, original monkeypox disease occurrence data,
with varying levels of care and effort: the first based on an automated web-service, the second improving on the
first by reference to additional maps and digital gazetteers, and the third improving still more based on extensive
consultation of legacy surveillance records that provided considerable additional information about each case. To
illustrate the implications of these seemingly subtle improvements in data quality, we develop ecological niche
models and predictive maps of monkeypox transmission risk based on each of the three occurrence data sets.
Results: We found macrogeographic variations in ecological niche models depending on the type of
georeferencing method used. Less-careful georeferencing identified much smaller areas as having potential for
monkeypox transmission in the Sahel region, as well as around the rim of the Congo Basin. These results have
implications for mapping efforts, as each higher level of georeferencing precision required considerably greater
time investment.
Conclusions: The importance of careful georeferencing cannot be overlooked, despite it being a time- and
labor-intensive process. Investment in archival storage of primary disease-occurrence data is merited, and improved
digital gazetteers are needed to support public health mapping activities, particularly in developing countries,
where maps and geographic information may be sparse.* Correspondence: rlash@cdc.gov
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Georeferencing is an essential first step towards enabling
GIS-based analyses of public health data [1,2]. It is the
process by which textual descriptions of the geographic
provenance of cases and diagnostic specimens are trans-
formed into digital spatial data (longitude and latitude
coordinates; “geocoding” is generally used to refer to the
simpler process of adding geographic coordinates to
postal addresses) [3]. The georeferencing process has
been generalized into the following components: input
records, reference datasets (e.g., gazetteers), and a geore-
ferencer (the algorithm used to normalize, standardize,
and match input records to the reference dataset) [4].
Ideally, the process is documented with detailed meta-
data [5].
The value of georeferenced public health data to state [6]
or national [7,8] public health systems is clear, as it enables
all spatial data analysis. However, nearly all research on the
efficiency, reliability, and accuracy of georeferencing meth-
ods has relied on examples of contemporary input records
and reference datasets from North America and Europe
[9], possibly because georeferencing methods evolve as the
availability and accuracy of reference datasets increase [4].
In contrast, our study compares three georeferencing
approaches to legacy monkeypox data from villages across
Central and West Africa.
Qualitative assessments of different georeferencing
methods for public health data have been developed pre-
viously [10-14]. Efforts aimed at georeferencing public
health data in data-poor parts of the world include tryp-
anosomiasis in Africa [15] and malaria globally [16].
However, although these studies acknowledge the chal-
lenges faced during the georeferencing process for loca-
tions where reference data are sparse or of poor quality,
they do not provide a comparison of various georeferen-
cing methods that could guide future studies needing
georeferenced disease data.
Monkeypox background
Monkeypox (MPX) virus was first identified as an agent
of human disease in 1970 in the Democratic Republic of
Congo (“DRC,” then Zaire) [17]. Prior to that date, MPX
virus had been isolated only from captive cynomologous
monkeys [18]. MPX presents clinically in a manner
nearly indistinguishable from smallpox, and thus was
cause for great concern among public health officials
trying to eradicate smallpox [19].
During 1970–1986, human MPX cases were identified
from seven countries across Central and West Africa as
a result of localized active disease surveillance efforts
(summarized in Figure 1). MPX cases have since been
identified in Gabon [20] and the Republic of Congo [21].
Even more recently, a limited outbreak of human MPX
in the United States was linked to rodents importedfrom Ghana [22], and human MPX cases have been
identified in South Sudan [23].
An MPX-specific research agenda was outlined in
1969 to address the problems that MPX posed to the
smallpox eradication campaign [25]. Under this plan,
World Health Organization (WHO) Collaborating Cen-
ters in the United States and the former Soviet Union,
the Centers for Disease Control (CDC), and the Moscow
Research Institute for Viral Preparations, respectively,
provided laboratory diagnostic services, enabling new in-
formation on MPX to be assembled. This collaborative
work supported serological studies during the 1970’s and
into the 1980’s [26]: surveillance activities intensified
during 1981–1986 [26-28], when 21,994 specimens were
tested from Congo, Ivory Coast, Sierra Leone, and Zaire
[24]. During this period of intensified surveillance, 228
cases were confirmed by electron microscopy or virus
culture; only 99 cases were confirmed based on serology
alone, while 11 additional cases died before specimens
could be collected. In all, during 1970–1986, 404 cases
of human MPX disease were documented and confirmed
[24].
Collection of diagnostic specimens from suspected
cases of MPX followed a system established by WHO
during the smallpox eradication campaign [25]. Staff at
local health facilities were responsible for completing
semi-standardized case forms at the time diagnostic spe-
cimens were collected from patients. Specimens and
forms were sent to WHO Headquarters in Geneva,
Switzerland, where they were divided and sent on to the
two collaborating centers. After diagnostic testing, a
diagnostic result form was generated by the lab; results
were either cabled to WHO Headquarters, or sent dir-
ectly to personnel in the field.
During the active surveillance period, summary infor-
mation from the case forms for the 404 confirmed cases
was organized in data tables. Later, WHO researchers
generated a digital spreadsheet of individual case infor-
mation; the geographic information in this spreadsheet
enabled subsequent MPX research [29]. The spreadsheet
contains five hierarchical place name fields for each case:
country, region, district/zone, town, and locality. Unfor-
tunately, details of the provenance of the data on the
WHO spreadsheets are not known. In 2007, CDC
researchers discovered that in the late 1980’s, after much
of the initial research agenda regarding orthopoxviruses
had been completed, many of the CDC laboratory diag-
nostic records were converted to microfilm and the ori-
ginals likely destroyed. The microfilm has since been
scanned digitally, and converted to PDF formats. Prelim-
inary comparisons of data from a few case forms against
the information in the WHO spreadsheet identified sev-
eral inconsistencies, which served as a motivation for
this study.
Figure 1 Total reported MPX case distribution across Central and West Africa, 1970–1986. The distribution of MPX cases in seven
countries where MPX cases were reported through the joint WHO/CDC surveillance efforts, including the total number of cases identified within
each county [24]. Countries labeled in gray without numbers indicate locations where additional MPX or MPX-related disease have occurred since
1986 [20-23].
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ology research is based on GIS mapping and modelling
techniques used to search for patterns between the loca-
tions of case occurrences and geographic and environ-
mental variables [24,29-31]. Historically, broad
association of MPX virus and tropical forest was
observed in early MPX research [32-34]; later,
continental-scale ecological niche models showed that
disease occurrence had stronger association with mean
annual precipitation than with land cover [29]. Subse-
quent analyses at finer spatial scales constrained to
within the Congo Basin, however, pointed back to prox-
imity to dense forest [30], probably reflecting different
scales and resolutions. However, studies to date have not
considered the quality of the georeferencing of the case
occurrence data used as model inputs—this point, al-
though seemingly a simple methodological step, ends up
being quite important.
Here, we test the hypothesis that different levels of ef-
fort invested in the georeferencing process can introduce
considerable biases into geographic models of disease
transmission. Specifically, we produce three georeferen-
cing data sets for the MPX disease occurrences based on
the same original WHO data, but differing in the detail
and care with which they were derived. The first was
based on automated georeferencing modules developed
to facilitate the georeferencing process for biodiversity
data (“automated data set”). Such automated approaches
approximate the level of care and attention that many
researchers pay to this step, and indeed exceed greatly
the standards of some studies, which have depended on
Internet search engines such as Google, Bing, and Yahoo
maps, along with Open Street Map. The second data set,
or “worked data set,” was developed by consulting abroader suite of geographic data sources to refine the
first. This method explores the results one might obtain
if not intimately aware of the nuances of a set of disease
data. The final data set, or “researched data set,” was
developed by consulting both geographic datasets and
legacy CDC records (“researched data set”). This method
represents the product of exhaustive searches for the
greatest number of highest-quality georeferences could
produce for our study system.
To compare the results of these methods, we devel-
oped ecological niche models and maps of potential
MPX distributions based on each of the three occur-
rence data sets, and thereby can assess the effects of the
different georeferencing methods on maps of MPX
transmission risk (this latter defined for the purposes of
this particular example as the potential for transmission
at a site, given its environmental characteristics and geo-
graphic position).
Methods
Georeferencing
We used the point-radius approach [5] and implemented
the recommended metadata architecture [35] to docu-
ment the georeferencing process in the production of all
three data sets. This approach captures (1) the original
data, such that the lineage of information is preserved
back to its source; (2) all decisions and assumptions
made in the course of the georeferencing process; (3)
the georeferenced coordinates, in a specified format and
datum; and (4) a summary of uncertainty associated with
the georeference. This summary of uncertainty repre-
sents an integration of uncertainty inherent in the geo-
graphic reference (e.g., an incomplete description),
uncertainty in components of the geographic reference
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miles, and anything between northeast and southeast),
and uncertainty in the underlying geography (e.g., the
spatial footprint of the site referred to, distances among
‘multiple hits’ in matching gazetteer data). It is expressed
as the radius of a circle that sums the diverse sources of
uncertainty in the georeference. We relied on the MaNIS
georeferencing calculator for estimating positional un-
certainty [36] and excluded any locality with an uncer-
tainty greater than 10 km.
Automated data set
The methods for producing the automated data sets are
similar to the single-stage georeferencing methods
described elsewhere [10,37]. We used the automated
georeferencing facility implemented in the Biogeoman-
cer workbench [38]. This free, web-based platform auto-
mates georeferencing by taking the WHO spreadsheet
input data, and searching for matching localities in the
National Geospatial-Intelligence Agency’s (NGA)
GEOnet Names Service (GNS) database [39], and then
automatically calculating and populating the MaNIS
metadata fields [40]. We reduced the initial set of input
data to unique textual locality records, and submitted
the resulting table of country, state, district, municipal-
ity, and locality records to Biogeomancer for automated
georeferencing.
Worked data set
The methods for producing the worked data sets are
akin to multi-stage georeferencing methods described
elsewhere [10,37], wherein we attempted to match
manually input data for which satisfactory georeferences
were not produced by the automated method. Here, the
initial Biogeomancer output was processed further by a
person knowledgeable in African geography (ATP), but
without access to the case reports. Using the automated
output from the Biogeomancer Workbench facility (see
above) as a starter, the data were explored further, refin-
ing initial automated results using locality information
on the Biogeomancer site, and incorporating additional
information from additional sources: gazetteer data [41],
Google Earth, and general Internet searches. The object-
ive was to ascertain the location of each record with
greater precision, and to describe uncertainty [5] more
accurately. This step involved 5–30 minutes of work per
locality, and the result is referred to as our “worked”
dataset.
Researched data set
The method used for georeferencing the researched data
departs considerably from the previous two methods,
and may be characterized as an iterative, detailed clerical
review [42]. It is distinguished from the previous twomethods because it utilized legacy primary disease data
to refine the input data, and it consulted a broader range
of geographic reference material than those used in the
automated and researched methods. The CDC legacy
case form provided the basis for modifying and refining
the input data, based on the assumption that the WHO
spreadsheet contained transcription and other typo-
graphical errors. Additional legacy data was used to en-
rich the available geographic reference material, by
compiling all available historic maps of MPX case loca-
tions into a common GIS map document to easily overlay
and compare geographic information from different
sources [17,19,24,27,32-34,43-51]. GNS geographic refer-
ence data was further supplemented with Joint Operation
Graphics (JOG) topographic reference maps [52,53].
The workflow used to produce this dataset for MPX
cases was iterative, as persistent and repeated searches
sometimes turned up additional useful information. The
initial step was to identify and resolve discrepancies be-
tween the input data from the WHO spreadsheet and
the available case forms. Next, we examined all informa-
tion available about individual cases to construct a
sound spatial logic for identifying locations. When dis-
crepancies were encountered, information from different
sources had to be prioritized. We deemed original case
forms as the most authoritative, but these records were
not available for all cases. If original case forms were un-
available, the earliest published journal article reports
were prioritized. If these two sources proved unhelpful,
then information in review articles or marginal annota-
tions was considered.
Once we had verified the geographic information for a
given case, we began the search for a matching reference
location. Our general strategy for assigning a georeference
was to consult the JOG maps first, which had the finest
spatial resolution, using all available information sources
to find the locality on JOG maps (sometimes including
preliminary GNS searches). If no location could be found
or inferred there, then less-detailed data resources were
used in order of decreasing precision. To expedite locating
areas of interest within the JOG maps, GNS was consulted
because it could be queried electronically. If a single GNS
match was found, then the location could frequently be
confirmed on the JOG maps and more precise coordinates
recorded. If no probable match was found in GNS, or if
more than one location had the same place name, then in-
formation from alternative data sources was used to guide
searches. In all cases, prior to model development (see
below), we discarded localities for which the uncertainty
radius exceeded 10 km.
We evaluated the quality of results for each of the
georeferencing methods based on completeness, pos-
itional accuracy, concordance, and repeatability [13].
Completeness is determined by the number of locations
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nates. Positional accuracy is determined here by the spatial
resolution of the geographic reference dataset. Concord-
ance is difficult to quantify in this study, as it assesses
whether the georeferenced coordinates match truthfully
those referenced by the locality place name. Since this
study is based on historical data for which it is impossible
to revisit, our measure of concordance is the number of
localities falling within the political geography boundary
cited in the original data record. Repeatability is largely
determined by the georeferencing methodology.Ecological niche model comparisons
Ecological niche modeling is a methodology that has seen
extensive use in recent years [54], and that has seen in-
creasing applications to understanding disease geography
[55]. We used a simple application of the methodology, as
the purpose of these analyses was only to test whether dif-
ferent georeferencing methodologies identify different
areas as “at risk” of MPX transmission. In particular, we
developed models using the Genetic Algorithm for Rule-
set Prediction, or GARP [56], based on default settings,
save for generating 100 random replicate models instead
of 20, and derived a consensus model that summed the 10
models with lowest omission error out of the original 100
models.
We analyzed known MPX occurrences for each of the
three georeferencing approaches in the context of 7
dimensions of climate drawn from the WorldClim climate
data set [57]. Specifically, we used annual mean tem-
perature, mean diurnal range, maximum temperature of
warmest month, minimum temperature of coldest month,
annual precipitation, and precipitation of the wettest and
driest months, which represent a diverse and relatively
uncorrelated environmental space in which to calibrate
models [58]. All analyses were conducted at 2.5’ spatial
resolution, which is equivalent to ~6.5 km near the Equa-
tor. The niche model results were summarized as maps of
putative suitable conditions, and compared by means of
calculation of difference maps on a pixel-by-pixel basis.Results
Differences in georeferencing methods
The 404 recorded MPX cases in the WHO spreadsheet
came from 231 unique localities, a figure which may vary
slightly depending on whether spelling variations are
interpreted as valid entries or human error. The auto-
mated method successfully georeferenced only 69/231 lo-
calities (30% match rate); the worked method successfully
georeferenced 116/231 localities (50% match rate), while
the researched method successfully georeferenced 106/
231 localities (match rate = 46%). Match rates for each
method are broken down geographically in Table 1.The georeferencing process for the researched data set
is of particular interest. During this process, 48 locations
were georeferenced using the input data as listed in ori-
ginally in the WHO spreadsheet; georeferencing
remaining localities involved careful checking against
primary records and/or alternative sources of geographic
information. Table 2 summarizes the relative utility of
the additional data resources used: CDC legacy records
and JOG maps provided the most valuable information,
followed by a coarse-scale (1:1,000,000) map that pro-
vided information on 7 localities [49]; several useful arti-
cles came from Ebola virus outbreak investigations,
which covered many of the same villages.
The above discussions of development of georefer-
enced public health data sets may all be inconsequential
if the additional precision and documentation that they
provide make no tangible difference to the outcome of
analyses. That is, if the results of analyses are qualita-
tively the same with such high-quality data as with less-
carefully-prepared data, then no reason exists to invest
time in the processes outlined above. Comparing the
distribution of localities of these three datasets
(Figure 2A), no MPX occurrences along the eastern,
southeastern, and northeastern limits of the known dis-
tribution of the pathogen were reliable, as none could be
substantiated in the researched data set.
The spatial projections of the three niche models identi-
fied areas that differed consistently. In brief, the researched
data set identified broader areas throughout West Africa,
as well as broader areas to the southwest and east in the
Congo Basin (Figure 2B). Visualizing the occurrence
points in a simple environmental space (annual mean
temperature X annual precipitation; Figure 2E), we see
that, although researched points define most of the
extremes of the distribution of the pathogen, the points
with lowest annual rainfall come from the automated data-
set only. Additionally, only the worked dataset includes
areas of both high temperature and high precipitation.Discussion
The method with the best match rate overall was the
worked dataset (50% match rate overall), followed by the
researched dataset (46%), and finally the automated
dataset (30%) (Table 1). Comparing match rates by
country shows that the worked dataset achieved 100%
success only in Ivory Coast, whereas the researched
dataset achieved 100% success in Ivory Coast, Liberia,
Nigeria, and Sierra Leone; the automated dataset did not
achieve 100% success in any country. The researched
data set was successful, for example, in Liberia, because
a detailed map and set of site descriptions [47] were
among the materials that it used. A previous study [29]
georeferenced 156 of 231 locations (68% match rate),
Table 1 Comparison of georeferencing match rates across countries and sub-national units for each different method
Researched Worked Automated
Country
Sub-national unit WHO Locations Matched % Matched % Matched %
Cameroon 2 0/2 0 1/2 50 0/2 0
Centre 2 0/2 0 1/2 50 0/2 0
Central African Republic 2 0/2 0 0/2 0 0/2 0
Sangha 2 0/2 0 0/2 0 0/2 0
Democratic Republic of the Congo 220 99/220 45 112/220 51 67/220 30
Bandundu 37 14/37 38 23/37 62 12/37 32
Bas Zaire 0 0/0 n/a 0/0 n/a 1/0* n/a
Equateur 143 62/143 43 71/143 50 38/143 27
Haut Zaire 3 2/3 67 9/3* n/a 8/3* n/a
Kasai Occidental 3 2/3 67 1/3 33 2/3 67
Kasai Oriental 31 19/31 61 6/31 19 5/31 16
Kivu 3 0/3 0 2/3 67 0/3 0
Shaba 0 0/0 n/a 0/0 n/a 1/0* n/a
Ivory Coast 2 2/2 100 2/2 100 1/2 50
Abengourou 1 1/1 100 1/1 100 0/1 0
Haut-Sassandra 1 1/1 100 1/1 100 1/1 100
Liberia 2 2/2 100 0/2 0 0/2 0
Grand Gedeh 2 2/2 100 0/2 0 0/2 0
Nigeria 2 2/2 100 1/2 50 1/2 50
East Central 1 1/1 100 0/1 0 0/1 0
Oyo 1 1/1 100 1/1 100 1/1 100
Sierra Leone 1 1/1 100 0/1 0 0/1 0
Southern 1 1/1 100 0/1 0 0/1 0
Overall 231 106/231 46 116/231 50 69/231 30
The number of MPX case localities were matched at different rates in different national and sub-national units (i.e. state or province), which are expressed as
fractions and percentages, relative to numbers of unique localities reported there in the WHO spreadsheet. Bolded regions in the DRC represent likely errors of
commission, where more localities were georeferenced than would be expected based on the WHO spreadsheet. Asterisks identify probable specific instances of
this type of error, such that calculating match rate percentages are not useful.
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in detail.
While comparing match rates across each country pro-
vides a metric of how well different georeferencing methods
performed broadly across the continent, 220/231 (95%) of
MPX cases occurred in the DRC. In the DRC, the worked
method achieved a match rate of 51%, the researched
method 45%, and the automated method only 30%. Issues
of concordance arise, however: for example, consider num-
bers of cases georeferenced in the DRC regions of Bas
Zaire, Haut Zaire, and Shaba. The worked method identi-
fied 9 localities in Haut Zaire, but the WHO spreadsheet
indicated only three (marked with an asterisk in Table 1).
The automated method had even lower concordance, iden-
tifying 8 localities in Haut Zaire, one in Bas Zaire, and one
in Shaba, when the WHO spreadsheet showed three in
Haut Zaire and none in the other two regions.Additional issues of concordance may go undetected
in these automated and worked datasets, as it is not en-
tirely clear how these methods dealt with multiple ‘hits,’
i.e., several places having the same name. In the
researched processing, localities were only entered into
the database if the locations fell within the indicated pol-
itical geographic unit, which reduced match rates by ex-
cluding some questionable localities that did have valid
returns; however, it minimized the probability of includ-
ing sites falsely. Under the other two methods, this con-
flicting evidence was clearly viewed subjectively (worked
data) or managed in unknown ways depending on dis-
tances among the multiple localities (automated data).
Information resources for georeferencing
When georeferencing historical disease data for foreign
locations, this study shows that georeferencing results
Table 2 Geographic information resources consulted for
“researched” dataset
Localities Name Reference
43 Joint Operation Graphic’s (JOG’s) [52]
18 Legacy CDC case forms
Reports
4 Report of Meeting on the implementation of
Post-Smallpox Eradication Policy
[49]
3 Human infections with MPX virus: Liberia and
Sierra Leone
[47]
Articles
3 The role of squirrels in sustaining MPX virus
transmission.
[50]
2 Ebola haemorrhagic fever in Zaire, 1976. [59]
4 A search for Ebola virus in animals in the
Democratic Republic of the Congo and
Cameroon: ecologic, virologic, and serologic
surveys, 1979–1980.
[46]
1 Human MPX. [19]
1 Human poxvirus disease after smallpox
eradication.
[48]
1 Four generations of probable person-to-person
transmission of human MPX.
[60]
1 Results of Ebola antibody surveys in various
populations groups
[61]
The number of MPX case localities which benefited from more detailed CDC
legacy data and other historic materials, by resource name.
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ence information, and consulting a variety of informa-
tion sources to check and validate input data. The
overall match rate improved considerably between the
automated method and the worked and researched
methods because the latter two methods utilized add-
itional geographic reference information beyond a single
gazetteer (e.g. GNS). While the overall match rate be-
tween the worked and researched methods were similar,
the researched method used more authoritative geo-
graphic information resources. The worked method
included the Falling Rain digital gazetteer [41] for which
there is no metadata about its data sources or standards.
In comparison, the researched method made extensive
use of the JOG maps, which have very detailed standards
and specifications [62].
The CDC legacy case forms were a unique and in-
formative resource that illuminated and modified the in-
formation in the WHO spreadsheet which has
previously been available to MPX specialists. These
records allowed us to seek details of geographic refer-
ence in several dimensions—place of residence, location
of the reporting clinic, etc. Such information may fre-
quently not be available for other disease systems, but
their utility in this study pointed clearly to theimportance of tracking down all levels of documentation
for disease case occurrences in such studies.
The legacy case forms posed challenges, though. They
were not available for all 404 cases; four different varia-
tions of the typed form had been used; and forms were
almost always completed by hand. In theory, cases for
which CDC provided confirmatory testing (n = 193)
should have been available; however, not all of these case
forms could be located. Generally, forms captured im-
portant information, including patient identification, pa-
tient history, health facility contact information,
examining physician, and regional surveillance team, and
each patient was assigned a unique identification num-
ber. Specific to the geographic information on the form,
a case’s place of residence was captured using a hier-
archy of place names, including the following fields:
name of region (e.g. administrative level-1), sub-region
(e.g. administrative level-2), zone (e.g. administrative
level-3), collectivité (a french term for a local govern-
ment administrative unit, e.g. administrative level-4),
and locality (e.g. village of residence). Only one of the
four versions of the case form included the sub-region
field. Two versions of the form included separate zone,
collectivité, and locality fields for where the affected per-
son was when illness began, and where the case had
resided two weeks prior to onset of symptoms; however,
this information was most commonly identical. One ver-
sion of the form did not have separate fields for each of
the hierarchical place names; rather, it asked for the
“complete address” of the case, and the person complet-
ing the form filled in abbreviated field names for collec-
tivité, zone, and region.
The JOG maps also proved useful for overcoming the
limited precision of the GNS data. It is worth noting that
when localities from the GNS data are overlaid on the
JOG maps in ArcGIS, the village locations between the
two do not align perfectly, apparently owing to the higher
spatial precision of the JOG maps (Figure 3). In GNS,
nearly all Congo Basin localities have been truncated to
the nearest 1’ (~2.6 km near the Equator), whereas the
scale of the JOG maps provides geographic precision finer
than 1 km. A limitation of both the GNS and JOG maps,
is the fact that little information is known about the tem-
poral provenance of the information in either resource.
Similar temporal problems with georeferenced data have
been noted elsewhere [63], and potential end users of the
data must be aware that no solution is readily available.
While the GNS data set provides a helpful textual
search functionality, JOG maps (which must be
inspected visually by the user) allow more accurate geor-
eferencing. Operationally, using GNS and the JOGs in
tandem was the most efficient process. If a locality could
be found using the text-based search in GNS, it could
frequently be found and georeferenced with greater
Figure 2 Exploration of effects of different levels of care and detail in georeferencing of human MPX cases on derivative transmission
risk maps. Models derived from the automated and worked occurrence data differ in environmental and geographic dimensions from those
based on the carefully researched occurrence data points. See text for additional detail. Red and orange areas in panels C and D are those that
are more extensive in the researched data set, while blue areas are those that are less extensive. Panel E highlights portions of the ecological
niche unique to the West African countries (Nigeria, Ivory Coast, Liberia, Sierra Leone) which were located using the researched method, but
largely missed by the other two methods.
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be identified in GNS at the locality level, the next-higher
unit place name (county, district, etc.) could frequently
be found on the JOG maps, which then guided visual
searches of the JOG maps for the locality—many of the
place names found on JOG maps have not been cap-
tured in the GNS database. Because JOG maps were not
available for our entire study area, some potential exists
for spatial bias in the resulting georeferencing database.
However, such areas were not omitted completely be-
cause some records could be georeferenced via other in-
formation resources, so we neglect this source of bias in
our results.
The following provides an example of one of the
unique and more complex instances of the georeferen-
cing process, for the locality “Libela.” Libela was
recorded as a MPX occurrence locality from a case in1972, but was not found in either the GNS database or
the JOG maps. Likely alternative spellings (e.g., Libella,
Lebella, etc.) were considered, but again no matching
records were found. After an Internet search using Goo-
gle, a reference to Libela was identified in the proceed-
ings of a conference on Ebola virus held in 1977, where
the author notes a fatal case of possible hemorrhagic
fever “in Libela (38 km south of Yambuku) [61].” Figure 3
shows a portion of a JOG map near Yambuku Mission
(not labeled on the map, but noted with a church
symbol, and included in the GNS database). Following
the only road south from Yambuku for 38 km leads to
an unlabeled populated place symbol, which we inferred
to be Libela. Hence, in this example, we had to use the
conjunction of GNS and JOG to identify Yambuku, and
then non-standard Internet resources to find the rela-
tionship of Libela to Yambuku.
Figure 3 Example of application of complex spatial logic to
georeferencing a difficult locality. A portion of a JOG map is
shown, with GNS gazetteer data overlaid as orange dots with
orange labels. The village of Libela did not appear on either the JOG
map or in the GNS database, but anecdotal reference was made to
it as being 38 km south of Yambuku [61]. Using ArcGIS, a 38 km
distance (solid white line) from Yambuku Mission (church symbol on
JOG map highlighted in white) to the south led to an unnamed
village on the JOG map 38 km away, which could reasonably be
inferred to be Libela.
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The extra effort invested in the ‘researched’ data set
impacted the results of the ecological niche models. As
the data in Table 1 shows, the researched dataset
matched all of the West African locations (Nigeria, Ivory
Coast, Liberia, Sierra Leone), but both the automated
and worked datasets failed to locate many of the cases in
this region (Figure 2A). Ecological niche models gener-
ated from the results of the researched method
(Figure 2B) therefore include more area in West Africa
as part of their predictions. However, models generated
from the results of automated (Figure 2C) and worked
(Figure 2D) georeferencing methods largely do not in-
clude much of these West African locations in their pre-
dicted distribution. The ecological conditions
represented by the West African locations are different
than much of the rest of the MPX ecological niche, as
shown in the highlighted portion of Figure 2E. Areas
along the northern and southern edges of the Congo
Basin were more variable in the effects of researching
data points, as the signals from the worked and auto-
mated data sets differed for these areas.
Even without the modeling step, the exercise of inves-
tigating each occurrence record in great depth was illu-
minating, and the linking of individual diagnostic results
with each unique location proved insightful. No
researched data point fell in the eastern quarter of the
Congo Basin. Biologically more importantly, however, no
researched data point comes from the Republic of the
Congo, on the west side of the Congo River above
Kinshasa. This latter area has not seen massive political
conflicts, so this absence may in fact be real; research is
underway into the causes of this lack of records from
the region. Since the relational database created was able
to incorporate data on confirmatory lab test as well, we
can state that laboratory confirmation of MPX by viral
culture occurred in 70 (66%) of the 106 localities in the
researched data set, a higher standard for disease con-
firmation than serology testing alone. Hence, earlier
studies based on the less carefully researched WHO
spreadsheet [29] must be taken with a grain of salt: quite
simply, different georeferencing have very-real implica-
tions for results of mapping exercises.
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This paper contributes uniquely because we document
the difficulties and limitations in the available methods
for georeferencing under challenging conditions, namely
historic disease data in foreign locations with poor geo-
graphic reference information. We demonstrate the util-
ity of institutional legacy data and importance of
consulting a variety of geographic data resources to the
process of georeferencing. We show meaningful differ-
ences in the resulting MPX distribution depending on
the georefrencing method chosen. While other studies
have encountered and identified similar difficulties to
georeferencing historic public health data from develop-
ing countries [15,16], the MPX data used in this study
are even older; we believe that our results may help
other researchers in the future to plan strategically for
georeferencing other historic public health data sets.
Elsewhere, analyses are appearing in the literature using
ecological niche modeling or other related GIS based
modeling methods to examine disease distributions in
various locations and at various spatial scales e.g., [64-
67]. Too often, however, occurrence data are used with-
out careful introspection or the georeferencing process
is executed without detailed attention.
Such concerns have seen considerable discussion
and development in the biodiversity informatics world
[5,68-70]. In public health, a clear and robust argument
of the need for georeferenced health data was put forth
nearly 15 years ago [71]. Since then, a large amount of
research has focused on georeferencing domestic disease
occurrences [1,11,72-74]. The work herein, like that of
Serebriakova [75], suggests that greater investment in
georeferencing resources for international public health
research is needed, and that legacy map library collec-
tions should be used to fill gaps in digital gazetteer data
[76]. In this vein, automated approaches to extracting in-
formation from scanned maps [77] may offer even
greater efficiency than manual digitizing. Discussions
have begun as regards alternative formats for capture of
human disease occurrence data [78,79], but much more
contemplation is needed, owing to differences in disease
surveillance systems and geographic information infra-
structure around the world. Emerging technologies may
be one way of strengthening public health surveillance
capacity, such as monitoring Twitter feeds [80], and
other types of mobile communications [81]. In light of
the ongoing threat posed by emerging and re-emerging
infectious diseases [82], it seems most advantageous to
initiate a focus on constructing high-quality, well-
documented geographic summaries of primary disease
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